Case Report: Recurrent uterine inflammatory myofibroblastic tumor harboring IGFBP5-ALK fusion with sustained response to iruplinalkib

Inflammatory myofibroblastic tumor (IMT) is an extremely rare mesenchymal tumor with approximately 50% of cases harbor anaplastic lymphoma kinase (ALK) gene rearrangements. The tyrosine kinase inhibitor (TKI) treatment has been increasingly common for IMTs with ALK fusions, but evidence for the effi...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Ke Zhao, Min Hu, Runfeng Yang, Yi Huang
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2026-06-01
Ráidu:	Frontiers in Oncology
Fáttát:	IGFBP5-ALK fusion inflammatory myofibroblastic tumor iruplinalkib tyrosine kinase inhibitor uterine
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1851744/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!